Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-01-26

Clinical Trial Update: Effectiveness of an Immediate Postoperative Intravesical Instillation With Either Gemcitabine or Epirubicin in Patients With Urinary Bladder Cancer (Gemcitabine Epirubicin Normal SAline) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating immediate postoperative intravesical instillation with either gemcitabine or epirubicin for bladder cancer; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Epirubicin (epirubicin)
  • Gemcitabine (Gemcitabine)

Snippet

Sponsor: University of Thessaly | Conditions: Bladder Cancer | Phase 3 | Status: RECRUITING